MODIFICATION
B -- In Vitro and Non-Clinical Evaluation of Locally-Acting Topical Dermal and Ophthalmic Formulation Properties
- Notice Date
- 4/26/2019
- Notice Type
- Modification
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- 4041 Powder Mill Road Beltsville MD 20705
- ZIP Code
- 20705
- Solicitation Number
- 19-223-SOL-00023
- Response Due
- 5/16/2019
- Archive Date
- 5/17/2019
- Point of Contact
- Richard Robinson, Lead Contract Specialist, Phone 3017966508
- E-Mail Address
-
richard.robinson@fda.hhs.gov
- Small Business Set-Aside
- Total Small Business
- Description
- Amendment 1 : The purpose of this amendment is to respond to questions received during the solicitation question period. See attached for Amendment details. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (26-APR-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/19-223-SOL-00023/listing.html)
- Place of Performance
- Address: At Awardee Site
- Country: US
- Country: US
- Record
- SN05294576-F 20190428/190426230040 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |